Chart Check: This pharma stock hits fresh 52-week high in December; likely to scale Rs 24,000

For more than a decade, the stock has been taking support at a rising moving average followed by a breach of the intermediate falling trendline. In recent context, the stock is rising with the same characteristic,” he said.

More To Explore

Lupin Q1 PAT rises 16 pc at Rs 1,417 cr

Lupin Ltd has reported a remarkable sixteen percent surge in profit after tax for the first quarter, showcasing their continued success. The firm experienced considerable